Page last updated: 2024-10-29

staurosporine aglycone and Hodgkin Disease

staurosporine aglycone has been researched along with Hodgkin Disease in 1 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Renné, C1
Minner, S1
Küppers, R1
Hansmann, ML1
Bräuninger, A1

Other Studies

1 other study available for staurosporine aglycone and Hodgkin Disease

ArticleYear
Autocrine NGFbeta/TRKA signalling is an important survival factor for Hodgkin lymphoma derived cell lines.
    Leukemia research, 2008, Volume: 32, Issue:1

    Topics: B-Lymphocytes; Carbazoles; Cell Line, Tumor; Hodgkin Disease; Humans; In Situ Hybridization, Fluores

2008